Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220301054154N1Phase 3Completed
Phase 3, randomised, single-blind trial of sevoflurane (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Time to Bispectral Index 60 to 70, Time to loss of response to trapezius squeeze and 5 more. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220301054154N1.